Standard Biotools (LAB) Change in Accured Expenses (2010 - 2026)
Standard Biotools (LAB) reported Change in Accured Expenses of $1000.0 for Q1 2026, up 100.01% year-over-year from $499.97 in Q1 2025, and up 100.26% quarter-over-quarter from -$378000.0 in Q4 2025.
Standard Biotools (LAB) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has 17 years of Change in Accured Expenses data on file, last reported at $1000.0 in Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at $1000.0, up 100.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.5 million (up 403.66% YoY), and the FY2025 annual result was -$208000.0, down 125.52% from the prior year.
- Change in Accured Expenses advanced to $1000.0 in Q1 2026 per LAB's latest filing, from -$378000.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $10.2 million in Q3 2022 and troughed at -$11.5 million in Q4 2022.
- A 5-year average of $47823.5 and a median of $11000.0 in 2024 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses slumped 2991.56% in 2024, then jumped 71681.82% in 2025.
- A 5-year view of Change in Accured Expenses shows it stood at -$11.5 million in 2022, then jumped by 106.37% to $735000.0 in 2023, then plunged by 458.5% to -$2.6 million in 2024, then jumped by 85.65% to -$378000.0 in 2025, then surged by 100.26% to $1000.0 in 2026.
- Business Quant data shows LAB's Change in Accured Expenses at $1000.0 in Q1 2026, -$378000.0 in Q4 2025, and $27000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 74.30 Mn |
| 10 | Standard Biotools | 319.06 Mn | -136.11 Mn | 11.31 Mn | 1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,000.00 |
| Mar 31, 2026 | 1,000.00 |
| Dec 31, 2025 | -378,000.00 |
| Dec 31, 2025 | -378,000.00 |
| Sep 30, 2025 | 27,000.00 |
| Sep 30, 2025 | 27,000.00 |
| Jun 30, 2025 | 7.90 Mn |
| Jun 30, 2025 | 7.90 Mn |
| Mar 31, 2025 | -7.75 Mn |
| Mar 31, 2025 | -7.75 Mn |
| Dec 31, 2024 | -2.64 Mn |
| Dec 31, 2024 | -2.64 Mn |
| Sep 30, 2024 | 7.89 Mn |
| Sep 30, 2024 | 7.89 Mn |
| Jun 30, 2024 | 11,000.00 |
| Jun 30, 2024 | 11,000.00 |
| Mar 31, 2024 | -4.45 Mn |
| Mar 31, 2024 | -4.45 Mn |
| Dec 31, 2023 | 735,000.00 |
| Dec 31, 2023 | 735,000.00 |